Literature DB >> 7519954

KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes.

M Cassidy1, B Loftus, A Whelan, B Sabt, D Hickey, K Henry, M Leader.   

Abstract

This study documents the reactions of the monoclonal antibody KP-1, which detects histiocytes in paraffin sections, with 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes. The soft tissue sarcomas had been previously immunophenotyped. Positive staining was obtained in all categories of sarcoma except clear-cell sarcomas. Most categories of sarcoma showed staining in less than 10% of tumour cells although a minority of leiomyosarcomas showed more extensive staining. Five of 7 malignant melanomas were also positive while all lymphomas and carcinomas were negative. We conclude that KP-1 positivity is not helpful in supporting the histiocytic origin of a tumour and is of limited value in the differential diagnosis of soft tissue sarcomas or their separation from other categories of malignancy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519954     DOI: 10.1007/bf00195778

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  24 in total

1.  Distribution of the CD68 macrophage/myeloid associated antigen.

Authors:  K A Pulford; A Sipos; J L Cordell; W P Stross; D Y Mason
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

2.  Monocyte/macrophage infiltrate in 41 oligodendrogliomas. Paraffin-wax study.

Authors:  M L Rossi; J Buller; S A Heath; H B Coakham
Journal:  Pathol Res Pract       Date:  1991-03       Impact factor: 3.250

3.  Evaluation of CD68 and other histiocytic antigens in angiomatoid malignant fibrous histiocytoma.

Authors:  M E Smith; M J Costa; S W Weiss
Journal:  Am J Surg Pathol       Date:  1991-08       Impact factor: 6.394

4.  Malignant fibrous histiocytoma. Proliferative compartment and heterogeneity of "histiocytic" cells.

Authors:  H Iwasaki; K Yoshitake; Y Ohjimi; M Kikuchi; T Isayama; S Yoh; N Shinohara; M Enjoji
Journal:  Am J Surg Pathol       Date:  1992-08       Impact factor: 6.394

5.  Nodular fasciitis. Its morphologic spectrum and immunohistochemical profile.

Authors:  E A Montgomery; J M Meis
Journal:  Am J Surg Pathol       Date:  1991-10       Impact factor: 6.394

6.  KP1 (CD 68) staining of malignant melanomas.

Authors:  F Facchetti; G Bertalot; P G Grigolato
Journal:  Histopathology       Date:  1991-08       Impact factor: 5.087

7.  An analysis of the sensitivity and specificity of the cytokeratin marker CAM 5.2 for epithelial tumours. Results of a study of 203 sarcomas, 50 carcinomas and 28 malignant melanomas.

Authors:  M Leader; J Patel; C Makin; K Henry
Journal:  Histopathology       Date:  1986-12       Impact factor: 5.087

Review 8.  Anti-alpha 1-antichymotrypsin staining of 194 sarcomas, 38 carcinomas, and 17 malignant melanomas. Its lack of specificity as a tumour marker.

Authors:  M Leader; J Patel; M Collins; K Henry
Journal:  Am J Surg Pathol       Date:  1987-02       Impact factor: 6.394

9.  Immunohistochemistry of markers of histiomonocytic cells in malignant fibrous histiocytomas. A monoclonal antibody study.

Authors:  Y Soini; M Miettinen
Journal:  Pathol Res Pract       Date:  1990-12       Impact factor: 3.250

10.  Myoglobin: an evaluation of its role as a marker of rhabdomyosarcomas.

Authors:  M Leader; J Patel; M Collins; K Henry
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

View more
  3 in total

1.  Specificity of plasma cell antibody VS38.

Authors:  K Al-Janabi; M Cassidy
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

Review 2.  Radiation-induced malignant fibrous histiocytoma of the maxilla.

Authors:  Takafumi Satomi; Masato Watanabe; Tadayoshi Kaneko; Jun Matsubayashi; Toshitaka Nagao; Hiroshige Chiba
Journal:  Odontology       Date:  2011-04-13       Impact factor: 2.634

3.  Plexiform fibrohistiocytic tumor: a clinicopathological and immunohistochemical study of 39 tumors, with evidence for a CSF1-producing "null cell" population.

Authors:  Judith Jebastin Thangaiah; Nooshin K Dashti; Abbas Agaimy; Karen Fritchie; Andrew L Folpe
Journal:  Virchows Arch       Date:  2022-09-07       Impact factor: 4.535

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.